Objective and subjective measures of the pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled laboratory classroom setting
- PMID: 9564199
Objective and subjective measures of the pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled laboratory classroom setting
Abstract
In a randomized double-blind crossover study of children with attention deficit hyperactivity disorder (ADHD), the time course effects of four doses of Adderall (5, 10, 15, and 20 mg) and an inactive (placebo) control, and an active (Ritalin) control were evaluated. A laboratory classroom setting was established in which subjective (teacher ratings of deportment and attention) and objective (scores on math tests) measurements were taken every 1.5 hours across the day. In addition to significant time and dose effects of Adderall, significant time-of-day effects were documented in the placebo condition for the subjective measure of deportment and objective measures of performance. Regression analyses were used to estimate the magnitude of these baseline effects. Correlations across time were used to evaluate the test-retest reliability of each measure in the face of these time-dependent placebo effects. After placebo/time adjustments, within-subject correlations between pairs of measures were used to evaluate the validity of the math test as a measure of response to stimulant medication.
Similar articles
-
Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD.J Am Acad Child Adolesc Psychiatry. 2003 Jun;42(6):673-83. doi: 10.1097/01.CHI.0000046863.56865.FE. J Am Acad Child Adolesc Psychiatry. 2003. PMID: 12921475 Clinical Trial.
-
A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder.J Am Acad Child Adolesc Psychiatry. 2000 May;39(5):619-26. doi: 10.1097/00004583-200005000-00016. J Am Acad Child Adolesc Psychiatry. 2000. PMID: 10802980 Clinical Trial.
-
A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.Clin Ther. 2006 Feb;28(2):280-93. doi: 10.1016/j.clinthera.2006.02.008. Clin Ther. 2006. PMID: 16678649 Clinical Trial.
-
An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.Ann Pharmacother. 2009 Jun;43(6):1084-95. doi: 10.1345/aph.1L523. Epub 2009 May 26. Ann Pharmacother. 2009. PMID: 19470858 Review.
-
Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Clin Ther. 2008. PMID: 18555941 Review.
Cited by
-
Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study data.BMC Psychiatry. 2004 Sep 30;4:28. doi: 10.1186/1471-244X-4-28. BMC Psychiatry. 2004. PMID: 15458569 Free PMC article. Clinical Trial.
-
Comparative efficacy of two once daily methylphenidate formulations (Ritalin LA and Concerta) and placebo in children with attention deficit hyperactivity disorder across the school day.Paediatr Drugs. 2003;5(8):545-55. doi: 10.2165/00148581-200305080-00005. Paediatr Drugs. 2003. PMID: 12895137 Clinical Trial.
-
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3. Cochrane Database Syst Rev. 2023. PMID: 36971690 Free PMC article.
-
Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies.BMC Psychiatry. 2013 Sep 27;13:237. doi: 10.1186/1471-244X-13-237. BMC Psychiatry. 2013. PMID: 24074240 Free PMC article.
-
Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents.Cochrane Database Syst Rev. 2016 Feb 4;2(2):CD009996. doi: 10.1002/14651858.CD009996.pub2. Cochrane Database Syst Rev. 2016. PMID: 26844979 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical